Showing results (251-260 of 497) with videos related to

Sort By:
Pageof 50
Gastroenterology|September 5, 2024
Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's DiseasePablo A Olivera, Helena Martinez-Lozano, Haim Leibovitzh, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 9, 2015
Use of Biosimilars in Paediatric Inflammatory Bowel Disease: A Position Statement of the ESPGHAN Paediatric IBD Porto GroupLissy de Ridder, Matti Waterman, Dan Turner, et al.
Journal of Crohn'S & Colitis|August 10, 2017
Quality Items Required for Running a Paediatric Inflammatory Bowel Disease Centre: An ECCO PaperDan Turner, Adam Carle, Steven J Steiner, et al.
Clinical and Experimental Rheumatology|September 8, 2021
Seroprevalence of SARS-CoV-2 antibodies in patients with autoimmune inflammatory rheumatic diseasesTali Eviatar, Victoria Furer, Ari Polachek, et al.
International Journal of Environmental Research and Public Health|November 26, 2022
Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency VirusNir Bar, Noa Bensoussan, Liane Rabinowich, et al.
Inflammatory Bowel Diseases|March 17, 2017
Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn's DiseaseThomas D Walters, William A Faubion, Anne M Griffiths, et al.
Gastro Hep Advances|August 12, 2024
A Machine Learning Approach to Identifying Causal Monogenic Variants in Inflammatory Bowel DiseaseDaniel J Mulder, Sam Khalouei, Michael Li, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 23, 2020
Role of Thiopurines in Pediatric Inflammatory Bowel Diseases: A Real-Life Prospective Cohort StudyOhad Atia, Oren Ledder, Tehila Ben-Moshe, et al.
Journal of Hepatology|April 23, 2021
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipientsLiane Rabinowich, Ayelet Grupper, Roni Baruch, et al.
Journal of Crohn'S & Colitis|May 26, 2021
Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 StudyJoel R Rosh, Dan Turner, Anne Griffiths, et al.
Pageof 50